Ibiome Biology
Hefei
About Ibiome Biology
Ibiome Biology is an intestinal bacteria drug developer that focuses on the research and development of gut-brain axis living microorganisms and metabolite pharmaceuticals.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $13.9M
- Funding stage: Seed
- Last round: Seed (Nov 2023)
- Website: m.ibiome.com.cn
- Phone: 18096699959
Industries & Categories
Biopharma, Biotechnology, Product Research
Canonical: https://fsome.com/organization/ibiome-biology-108791 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.